The EEF2K Knockout HeLa Polyclonal Cells are a CRISPR/Cas9-edited human polyclonal knockout cell population targeting the EEF2K gene. This polyclonal format comprises a heterogeneous pool of HeLa cells carrying diverse gene disruptions introduced by CRISPR/Cas9, enabling robust loss-of-function analysis without the bias of clonal selection. The product provides a versatile tool to investigate the biological roles of EEF2K in translational control and stress response pathways.
The host HeLa cell line is an epithelial cell model derived from human cervical adenocarcinoma, widely used in cancer research and protein translation studies. HeLa cells are well-characterized for their active signaling networks and robust translational machinery, making them an ideal platform for generating knockout models to dissect molecular mechanisms in a disease-relevant context.
EEF2K encodes eukaryotic elongation factor 2 kinase, which phosphorylates its sole known substrate EEF2 at threonine 56, leading to inhibition of peptide chain elongation during mRNA translation. This kinase acts as a sensor of cellular energy and stress status, integrating upstream signals from AMPK, mTORC1, Ca2+/calmodulin, and cAMP/PKA pathways. Through its interaction with calmodulin, EEF2K translates environmental cues such as nutrient deprivation, hypoxia, and energy depletion into adaptive reductions in global protein synthesis, thereby linking metabolic and stress signaling to translational control.
In the context of HeLa cervical adenocarcinoma cells, EEF2K knockout provides a valuable model to examine how dysregulation of translation elongation impacts cancer cell behavior. Loss of EEF2K-mediated phosphorylation of EEF2 may alter protein synthesis dynamics, affecting proliferation, survival, apoptosis, and sensitivity to chemotherapeutic agents. This polyclonal knockout population is particularly suited for studying the interplay between oncogenic pathways and translational regulation, as HeLa cells harbor active mTOR and AMPK networks that converge on EEF2K.
Research applications span cancer biology, neurological disease mechanisms, metabolic disorders, and cellular stress responses. Representative assays include western blotting to detect phospho-EEF2 (Thr56), RT-qPCR for EEF2K transcript levels, polysome profiling to assess ribosomal occupancy, puromycin incorporation to measure nascent protein synthesis, and functional assays for cell viability, apoptosis, colony formation, and migration/invasion. This polyclonal knockout cell population enables both large-scale functional screens and detailed mechanistic studies while mitigating clonal artifacts. For further information or to discuss custom solutions, contact Ascent Research.
